Compare PDSB & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PDSB | TPCS |
|---|---|---|
| Founded | 2005 | 1956 |
| Country | United States | United States |
| Employees | 10 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.0M | 45.1M |
| IPO Year | 2015 | 2008 |
| Metric | PDSB | TPCS |
|---|---|---|
| Price | $0.76 | $4.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 246.2K | 23.0K |
| Earning Date | 05-14-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.16 | ★ 41.38 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $31,644,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.51 | $2.88 |
| 52 Week High | $1.55 | $6.25 |
| Indicator | PDSB | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 46.85 | 53.46 |
| Support Level | $0.63 | $4.41 |
| Resistance Level | $0.76 | $4.71 |
| Average True Range (ATR) | 0.04 | 0.16 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 76.46 | 58.97 |
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
Techprecision Corp manufactures precision, large-scale fabricated and machined metal structural components and systems. The company provides end-to-end services, transforming raw materials into precision finished products through custom fabrication, precision machining, assembly, integration, inspection, non-destructive evaluation, and testing. It manufactures products in accordance with customers' drawings and specifications while complying with applicable national and international industry codes and standards. Its segments are: Ranor, which generates the majority of revenue, and Stadco, both focused on the manufacture and assembly of components mainly for defense and other precision industrial customers.